Regulation of Adrenomedullin and its Family Peptide by RAMP System – Lessons from Genetically Engineered Mice
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Adrenomedullin (ADM), originally identified as a vasodilating peptide, is now recognized to be a pleiotropic molecule involved in both the pathogenesis of cardiovascular diseases and circulatory homeostasis. Homozygotes of ADM knockout mice (ADM-/-) were lethal at mid-gestation with abnormalities of vascular development and this finding clarified the angiogenic potency of ADM. Calcitonin gene-related peptide (CGRP), which has a structure and function similar to that of ADM, has been identified as a family peptide of ADM. Unlike ADM-/-, CGRP-/- were apparently normal. Therefore, the study of knockout mice first clarified the distinctly different physiological roles between ADM and CGRP. In contrast, heterozygotes of ADM knockout mice (ADM+/-) were alive but showed blood pressure elevation, reduced neovascularization, and enhanced neointimal formation by arterial injury. Based on these observations, there was hope ADM would have a therapeutic use. However, ADM has a short half-life in the blood stream and its application in chronic disease has limitations. Therefore, we focused on the ADM receptor system. The calcitonin-receptor-like receptor (CLR), which is the ADM receptor, associates with one of the accessory proteins, called receptor activity-modifying proteins (RAMPs). By interacting with RAMP1, CLR exhibits a high affinity for CGRP, whereas by interacting with either RAMP2 or -3, CLR exhibits a high affinity for ADM. We generated RAMP knockout mice and found that vascular phenotypes similar to ADM-/- were reproduced only in RAMP2-/-. This shows that RAMP2 is the key determinant of the vascular functions of ADM. RAMP2 could be an attractive therapeutic target in cardiovascular diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adrenomedullin regulates the proliferation, migration, and differentiation of various cell types and affects a large number of physiological and pathological processes, including hormone release, inflammation, and oxidative stress (189).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [189]
Citations
Cites
Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing
Rosenfeld, M. G., Mermod, J.-J., Amara, S. G., Swanson, L. W., Sawchenko, P. E., Rivier, J., Vale, W. W., & Evans, R. M. (1983) · Nature · doi:10.1038/304129a0 · Cited by 2,302 · cited 1×
“CGRP KNOCKOUT MICE Calcitonin gene-related peptide (CGRP) is a 37-amino acid vasoactive peptide produced by tissue-specific alternative splicing of the primary transcript of the calcitonin/CGRP gene([18]).”
BackgroundAdrenomedullin: A Novel Hypotensive Peptide Isolated from Human Pheochromocytoma
Kitamura, K., Kangawa, K., Kawamoto, M., Ichiki, Y., Nakamura, S., Matsuo, H., & Eto, T. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1451 · Cited by 2,192
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M. (1998) · Nature · doi:10.1038/30666 · Cited by 2,134 · cited 6×
“Abbreviations ADM = adrenomedullin CGRP = calcitonin gene-related peptide CLR = calcitonin-receptor-like receptor RAMP = receptor activity-modifying protein GPCR = G protein-coupled receptor KO = knockout WT = wild-type Tg = transgenic LSEC = liver sinusoidal endothelial cell 24 Figure legends Figure 1.”
BackgroundInfluentialDistribution and characterization of immunoreactive adrenomedullin in human tissue and plasma
Ichiki, Y., Kitamura, K., Kangawa, K., Kawamoto, M., Matsuo, H., & Eto, T. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80106-1 · Cited by 576
Ishimitsu, T., Nishikimi, T., Saito, Y., Kitamura, K., Eto, T., Kangawa, K., Matsuo, H., Omae, T., & Matsuoka, H. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117573 · Cited by 475
MCKEOWN, C. M. B., EDWARDS, V., PHILLIPS, M. J., HARVEY, P. R. C., PETRUNKA, C. N., & Strasberg, S. M. (1988) · Transplantation · doi:10.1097/00007890-198808000-00001 · Cited by 438
Caron, K. M., & Smithies, O. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.615 · Cited by 346 · cited 1×
“ADM KOCKOUT MICE Three independent groups including ours have reported the outcome of targeted ADM gene disruption([8]) [16] ([17]).”
BackgroundReperfusion injury to endothelial cells following cold ischemic storage of rat livers
Caldwell-Kenkel, J. C., Currin, R. T., Tanaka, Y., Thurman, R. G., & Lemasters, J. J. (1989) · Hepatology · doi:10.1002/hep.1840100307 · Cited by 340
Vascular Abnormalities and Elevated Blood Pressure in Mice Lacking Adrenomedullin Gene
Shindo, T., Kurihara, Y., Nishimatsu, H., Moriyama, N., Kakoki, M., Wang, Y., Imai, Y., Ebihara, A., Kuwaki, T., Ju, K.-H., et al. (2001) · Circulation · doi:10.1161/hc4101.097111 · Cited by 297
Self-citationMuff, R., Bühlmann, N., Fischer, J. A., & Born, W. (1999) · Endocrinology · doi:10.1210/endo.140.6.6930 · Cited by 273
Cited by
Wiping Out CGRP: Potential Cardiovascular Risks
MaassenVanDenBrink, A., Meijer, J., Villalón, C. M., & Ferrari, M. D. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.06.002 · Cited by 232
The Activity of Peptides of the Calcitonin Family in Bone
Naot, D., Musson, D. S., & Cornish, J. (2019) · Physiological Reviews · doi:10.1152/physrev.00066.2017 · Cited by 141
Adrenomedullin – new perspectives of a potent peptide hormone
Schönauer, R. A.-R., Els‐Heindl, S., & Beck‐Sickinger, A. G. (2017) · Journal of Peptide Science · doi:10.1002/psc.2953 · Cited by 89
Calcitonin and Bone Physiology: In Vitro, In Vivo, and Clinical Investigations
Xie, J., Guo, J., Kanwal, Z., Wu, M., Lv, X., Ibrahim, N. A., Li, P., Buabeid, M. A., Arafa, E. A., & Sun, Q. (2020) · International Journal of Endocrinology · doi:10.1155/2020/3236828 · Cited by 83
Schubert, M. L. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000125 · Cited by 53
Metadata
- Authors
- Shindo, T., Sakurai, T., Kamiyoshi, A., Ichikawa-Shindo, Y., Shimoyama, N., Iinuma, N., Arai, T., & Miyagawa, S.
- Affiliations
- Shinshu University (JP)
- Corresponding author
- Miyagawa, Shinichi
- Venue
- Current Protein & Peptide Science
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2013-07-01
- Volume
- 14
- Issue
- 5
- Pages
- 347-357
- ISSN
- 1389-2037 (ISSN-L)
- OpenAlex
- W2092576179
- Cited by
- 19
- References
- 47
- Citations by year
- 2025: 1 · 2022: 4 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 3 · 2016: 3 · 2015: 1 · 2014: 1
- FWCI
- 0.82
- Type
- journal article
- Language
- en
- Open access
- Locations
- Current Protein and Peptide Science (publishedVersion)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (acceptedVersion)
- SOAR (Shinshu University) (submittedVersion, cc-by-nc-nd)
- Funders
- Japan Society for the Promotion of Science (23590456)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Surgery › Cardiovascular, Neuropeptides, and Oxidative Stress Research
- Health Sciences › Medicine › Pharmacology (medical) › Apelin-related biomedical research
- Keywords
- adrenomedullin, calcitonin gene-related peptide, receptor activity-modifying proteins, RAMP2, calcitonin receptor-like receptor, adrenomedullin receptor, knockout mice, neointima formation, angiogenesis, neovascularization, blood pressure, cardiovascular disease, vasodilation, therapeutic target
- MeSH terms
- Animals, Calcitonin Gene-Related Peptide, Mice, Knockout, Neovascularization, Physiologic, Animals, Genetically Modified, Mice, Gene Regulatory Networks, Adrenomedullin, Receptor Activity-Modifying Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Regulation of Adrenomedullin and its Family Peptide by RAMP System – Lessons from Genetically Engineered Mice. https://app.cochat.ai/papers/10.2174/13892037113149990052
- The paper
- Shindo, T., Sakurai, T., Kamiyoshi, A., Ichikawa-Shindo, Y., Shimoyama, N., Iinuma, N., Arai, T., & Miyagawa, S. (2013). Regulation of Adrenomedullin and its Family Peptide by RAMP System – Lessons from Genetically Engineered Mice. Current Protein & Peptide Science. https://doi.org/10.2174/13892037113149990052
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.